6-7583758-C-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_004415.4(DSP):c.6496C>T(p.Arg2166*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000929 in 1,613,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R2166R) has been classified as Likely benign.
Frequency
Consequence
NM_004415.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- arrhythmogenic right ventricular dysplasia 8Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- keratosis palmoplantaris striata 2Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Genomics England PanelApp
- skin fragility-woolly hair-palmoplantar keratoderma syndromeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P, Genomics England PanelApp, Ambry Genetics
- arrhythmogenic cardiomyopathy with wooly hair and keratodermaInheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, ClinGen, Orphanet, Ambry Genetics
- cardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesisInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- lethal acantholytic epidermolysis bullosaInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- striate palmoplantar keratodermaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe dermatitis-multiple allergies-metabolic wasting syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DSP | NM_004415.4 | c.6496C>T | p.Arg2166* | stop_gained | Exon 24 of 24 | ENST00000379802.8 | NP_004406.2 | |
| DSP | NM_001319034.2 | c.5167C>T | p.Arg1723* | stop_gained | Exon 24 of 24 | NP_001305963.1 | ||
| DSP | NM_001008844.3 | c.4699C>T | p.Arg1567* | stop_gained | Exon 24 of 24 | NP_001008844.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251438 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461868Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727234 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74298 show subpopulations
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg2166*) in the DSP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 706 amino acid(s) of the DSP protein. This variant is present in population databases (no rsID available, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with arrhythmogenic right ventricular dysplasia/cardiomyopathy and acantholytic epidermolysis bullosa (PMID: 23671136, 27532257, 28442525). ClinVar contains an entry for this variant (Variation ID: 199903). This variant disrupts a region of the DSP protein in which other variant(s) (p.Glu2728Glyfs*11) have been determined to be pathogenic (internal data). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
DSP-related cardiomyopathy Pathogenic:1
The DSP c.6496C>T (p.Arg2166Ter) nonsense variant results in the loss of normal protein function through protein truncation. This variant occurs in the last exon of the gene and may escape nonsense-mediated mRNA decay. This variant has been identified in a heterozygous state in individuals with arrhythmogenic right ventricular cardiomyopathy (PMID: 23671136; 27532257) and dilated cardiomyopathy (PMID:32969603). This variant is not observed at a significant frequency in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. This variant has been previously classified as pathogenic by at least three submitters in ClinVar. Based on the available evidence, the c.6496C>T (p.Arg2166Ter) variant is classified as likely pathogenic for DSP-related cardiomyopathy. -
Cardiomyopathy Pathogenic:1
This variant changes 1 nucleotide in exon 24 of the DSP gene, creating a premature translation stop signal in the last exon. This variant alters C-terminal plakin repeat domains A, B and C that are essential for coalignment and binding of intermediate filaments (PMID: 12101406, 21756917) and is expected to disrupt protein function. This variant has been reported in at least three individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 23671136, 25820315, 27532257, 28588093, 29759408), in an individual affected with arrhythmogenic left ventricular cardiomyopathy (PMID: 35444050), and in another two individuals affected with dilated cardiomyopathy (PMID: 32969603, 37461109). This variant has been identified in 2/251438 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of DSP function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23810894, 23671136, 27532257, 31386562, 31402444, 33087929, 23871885, 32969603, 28442525, 36264615, 34352074) -
Cardiovascular phenotype Pathogenic:1
The c.6496C>T (p.R2166*) alteration, located in exon 24 (coding exon 24) of the DSP gene, consists of a C to T substitution at nucleotide position 6496. This changes the amino acid from a arginine (R) to a stop codon at amino acid position 2166. This alteration occurs at the 3' terminus of the DSP gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 25% of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). Based on data from gnomAD, the T allele has an overall frequency of 0.001% (2/251438) total alleles studied. The highest observed frequency was 0.003% (1/34590) of Latino alleles. Variants in DSP that result in haploinsufficiency or protein truncation have been reported in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and dilated cardiomyopathy (DCM) (Fressart, 2010; Elliott, 2010; Quarta, 2011; Garcia-Pavia, 2011; Rasmussen, 2013; Pugh, 2014). This variant has been identified in an individual meeting definite arrhythmogenic right ventricular cardiomyopathy (ARVC) Task Force Criteria (Bhonsale, 2013; Groeneweg, 2015). This variant has also been reported in monozygotic twins with acantholytic epidermolysis bullosa, who had another truncating DSP variant detected in trans (Kim, 2017). Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at